These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7177245)

  • 41. Local excision of ciliary body tumors: a long-term prospective cohort study in China.
    Wei WB; Yang WL; Hu SM; Li B
    Chin Med J (Engl); 2008 Nov; 121(21):2152-6. PubMed ID: 19080176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Matrix metalloproteinase-2 (MMP-2) immunoreactive protein--a new prognostic marker in uveal melanoma?
    Väisänen A; Kallioinen M; von Dickhoff K; Laatikainen L; Höyhtyä M; Turpeenniemi-Hujanen T
    J Pathol; 1999 May; 188(1):56-62. PubMed ID: 10398141
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Retrospective study of uveal melanoma].
    Tóth J
    Magy Onkol; 2005; 49(1):19-25. PubMed ID: 15902329
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma.
    Djukanovic D; Hofmann U; Sucker A; Rittgen W; Schadendorf D
    Anticancer Res; 2000; 20(3B):2203-7. PubMed ID: 10928178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of tube LAI assay in larynx cancer patients.
    Hasek M; Holán V; Síbl O; Kousalová M
    Neoplasma; 1981; 28(6):685-8. PubMed ID: 7040994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating melanoma-associated antigens in ocular melanoma.
    Whitmore WG; Witkin SS; Ellsworth RM
    Ann Ophthalmol; 1988 Jun; 20(6):212-7. PubMed ID: 3408088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
    Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
    Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
    Frenkel S; Hendler K; Pe'er J
    Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of leukocyte migration by soluble tumor extracts in human malignant melanoma.
    Lapińska M; Jassem J; Kondrat W; Jaśkiewicz J
    Neoplasma; 1980; 27(1):37-42. PubMed ID: 6154899
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
    Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
    Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Internal eye wall resection for posterior uveal melanoma.
    Lee KJ; Peyman GA; Raichand S
    Jpn J Ophthalmol; 1993; 37(3):287-92. PubMed ID: 8295367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Further experience with the test of inhibition of leucocyte adherence (LAI) in the diagnosis of melanoblastomas of the choroid (author's transl)].
    Kubát Z; Sachsová D; Jandová A; Heyberger K; Andrysek O
    Sb Lek; 1979; 81(11-12):333-6. PubMed ID: 390683
    [No Abstract]   [Full Text] [Related]  

  • 53. [Bilateral uveal melanomas. Five case reports].
    Bhouri L; Lumbroso L; Levy C; Dendale R; Asselain B; Plancher C; Sastre X; Desjardins L
    J Fr Ophtalmol; 2003 Feb; 26(2):149-53. PubMed ID: 12660588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.
    Freudenberg LS; Schueler AO; Beyer T; Antoch G; Kühl H; Bornfeld N; Bockisch A; Egelhof T
    Surv Ophthalmol; 2004; 49(5):537-40. PubMed ID: 15325198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Metastases in malignant melanoma despite histologically negative sentinel lymph node: should the concept be changed?].
    Weiss M; Konz B; Schmid-Wendtner MH; Sander C; Dresel S; Tatsch K; Volkenandt M; Hahn K
    Nuklearmedizin; 2000 Nov; 39(7):214-7. PubMed ID: 11127051
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Humoral leukocyte adherence inhibition (H-LAI) follow-up trials on malignant process in mice.
    Kubasova T; Pázmány T; Horváth M; Pál K; Köteles GJ
    Neoplasma; 1991; 38(1):63-8. PubMed ID: 2011211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metastatic uveal melanoma: an ocular melanoma associated antigen in the serum of patients with metastatic disease.
    Donoso LA; Felberg NT; Edelberg K; Borlinghaus P; Herlyn M
    J Immunoassay; 1986; 7(4):273-83. PubMed ID: 3805289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Peripheral blood leukocyte adherence inhibition (LAI) reactivity before and during progressive growth of B77 tumor in rats.
    Kalafut F; Klobusická M; Novotná L
    Neoplasma; 1984; 31(5):507-13. PubMed ID: 6390225
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The significance of vaginal hormonal cytology and the leukocyte adherence inhibition test for the detection of malignancy.
    Kobilková J; Jandová A; Motlík K; Coupek J; Heyberger K
    Acta Cytol; 1983; 27(4):417-20. PubMed ID: 6349199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune response to melanoma extracts in three melanoma-prone families.
    Vandenbark AA; Greene MH; Burger DR; Vetto RM; Reimer RR
    J Natl Cancer Inst; 1979 Nov; 63(5):1147-51. PubMed ID: 291746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.